Pharmacokinetics of FDL169 in Healthy Female Subjects
NCT02680418
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
FDL169
Sponsor
Flatley Discovery Lab LLC